Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Adam Chaker and Ioana Agache.
Adam Chaker
Connection Strength
0.329
Ioana Agache
  1. COVID-19 pandemic and allergen immunotherapy-an EAACI survey. Allergy. 2021 11; 76(11):3504-3516.
    View in: PubMed
    Score: 0.060
  2. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper. Allergy. 2021 03; 76(3):677-688.
    View in: PubMed
    Score: 0.058
  3. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement. Allergy. 2020 11; 75(11):2764-2774.
    View in: PubMed
    Score: 0.057
  4. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. 2020; 4:53-68.
    View in: PubMed
    Score: 0.056
  5. Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018. Allergy. 2019 04; 74(4):837-840.
    View in: PubMed
    Score: 0.050
  6. EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018 08; 73(8):1597-1608.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.